Compare NOTV & BNGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NOTV | BNGO |
|---|---|---|
| Founded | 1974 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Laboratory Analytical Instruments |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.7M | 11.6M |
| IPO Year | 1997 | 2018 |
| Metric | NOTV | BNGO |
|---|---|---|
| Price | $0.34 | $1.12 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 3 |
| Target Price | $1.50 | ★ $6.33 |
| AVG Volume (30 Days) | ★ 549.0K | 98.5K |
| Earning Date | 05-14-2026 | 03-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 49.64 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $547,656,000.00 | $12,000,735.00 |
| Revenue This Year | $5.28 | N/A |
| Revenue Next Year | $5.42 | $24.27 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 511.19 | 26.26 |
| 52 Week Low | $0.25 | $1.06 |
| 52 Week High | $3.35 | $5.50 |
| Indicator | NOTV | BNGO |
|---|---|---|
| Relative Strength Index (RSI) | 45.38 | 38.12 |
| Support Level | $0.26 | $1.06 |
| Resistance Level | $0.65 | $1.18 |
| Average True Range (ATR) | 0.05 | 0.04 |
| MACD | 0.02 | 0.01 |
| Stochastic Oscillator | 38.75 | 29.70 |
Inotiv Inc is a pharmaceutical development company specializing in nonclinical and analytical drug discovery, development services to the pharmaceutical, chemical, and medical device industries. It operates in two segments; Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through the DSA segment, the company supports the discovery, nonclinical development, and clinical development needs of researchers and clinicians for small molecule drug candidates, biotherapeutics, and biomedical devices. Through the RMS segment, the company offers access to a wide range of small and large research models for basic research, drug discovery, development, and specialized models for specific diseases and therapeutic areas. The company earns maximum revenue from RMS Segment.
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in the Americas, EMEA, and Asia Pacific, of which the EMEA region generates the majority of its revenue. It generates product revenue from sales of its OGM and Ionic Purification systems and consumables, which include its instruments and their VIA software.